Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

M1/M4 Agonist Relieved Schizophrenia Symptoms in Mid-Stage Trial

(MedPage Today) -- ML-007C-MA, an investigational muscarinic M1/M4 receptor agonist that combines betovumeline and fesoterodine fumarate, significantly improved schizophrenia symptoms in adults who had an acute exacerbation of psychosis, data from...

M1/M4 Agonist Relieved Schizophrenia Symptoms in Mid-Stage Trial

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

Namibia: Sangwali Raises Concern Over Healthcare, Stalled Development Projects

[New Era] Sangwali Health Centre in the Zambezi region is facing a mountain of challenges ranging from shortage of ambulances, inadequate medical facilities and deteriorating infrastructure, affecting…

  • Sangwali Health Centre faces ambulance shortage and infrastructure issues
  • Nurse reports delays due to single ambulance serving seven facilities
  • Traditional authority raises concerns over stalled development projects

More from Monday 9 November →